MAXNRH Trademark

Trademark Overview

On Tuesday, November 16, 2021, a trademark application was filed for MAXNRH with the United States Patent and Trademark Office. The USPTO has given the MAXNRH trademark a serial number of 97128438. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, April 2, 2024. This trademark is owned by MaxScientific Inc.. The MAXNRH trademark is filed in the Pharmaceutical Products category with the following description:

Dietary supplements; Pharmaceutical agents affecting metabolism, all of the foregoing containing Dihydronicotinamide Riboside (NRH)
maxnrh

General Information

Serial Number97128438
Word MarkMAXNRH
Filing DateTuesday, November 16, 2021
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, April 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 6, 2024

Trademark Statements

Goods and ServicesDietary supplements; Pharmaceutical agents affecting metabolism, all of the foregoing containing Dihydronicotinamide Riboside (NRH)

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 22, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMaxScientific Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMiddletown, DE 19709
Party NameMaxScientific Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMiddletown, DE 19709

Trademark Events

Event DateEvent Description
Thursday, March 24, 2022NON-FINAL ACTION E-MAILED
Friday, November 19, 2021NEW APPLICATION ENTERED
Monday, November 22, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 18, 2022ASSIGNED TO EXAMINER
Thursday, March 24, 2022NON-FINAL ACTION WRITTEN
Thursday, March 24, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 26, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 26, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 27, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 1, 2022NON-FINAL ACTION WRITTEN
Tuesday, November 1, 2022NON-FINAL ACTION E-MAILED
Tuesday, November 1, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 17, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, May 17, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, May 17, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, July 14, 2023TEAS PETITION TO REVIVE RECEIVED
Friday, July 14, 2023PETITION TO REVIVE-GRANTED
Friday, July 14, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, July 15, 2023NOTICE OF REVIVAL - E-MAILED
Tuesday, December 12, 2023ASSIGNED TO LIE
Wednesday, December 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 13, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 2, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 6, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 6, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 2, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, September 27, 2024TEAS STATEMENT OF USE RECEIVED
Monday, September 23, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 23, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 23, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, September 23, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Related Keywords

maxnrh foregoing containing dihydronicotinamide riboside metabolism affecting supplements pharmaceutical agents dietary